HK1057558A1 - Non-nucleoside reverse transcriptase inhibitors. - Google Patents

Non-nucleoside reverse transcriptase inhibitors.

Info

Publication number
HK1057558A1
HK1057558A1 HK04100468A HK04100468A HK1057558A1 HK 1057558 A1 HK1057558 A1 HK 1057558A1 HK 04100468 A HK04100468 A HK 04100468A HK 04100468 A HK04100468 A HK 04100468A HK 1057558 A1 HK1057558 A1 HK 1057558A1
Authority
HK
Hong Kong
Prior art keywords
reverse transcriptase
transcriptase inhibitors
nucleoside reverse
group
inhibitors
Prior art date
Application number
HK04100468A
Other languages
English (en)
Inventor
Bruno Simoneau
Original Assignee
Bohringer Ingelheim Canada Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bohringer Ingelheim Canada Ltd filed Critical Bohringer Ingelheim Canada Ltd
Publication of HK1057558A1 publication Critical patent/HK1057558A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
HK04100468A 2000-06-16 2004-01-21 Non-nucleoside reverse transcriptase inhibitors. HK1057558A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21232900P 2000-06-16 2000-06-16
US25663800P 2000-12-18 2000-12-18
PCT/CA2001/000890 WO2001096338A1 (en) 2000-06-16 2001-06-14 Non-nucleoside reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
HK1057558A1 true HK1057558A1 (en) 2004-04-08

Family

ID=26907019

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04100468A HK1057558A1 (en) 2000-06-16 2004-01-21 Non-nucleoside reverse transcriptase inhibitors.

Country Status (36)

Country Link
US (1) US6420359B1 (zh)
EP (1) EP1294720B1 (zh)
JP (1) JP3923894B2 (zh)
KR (1) KR20030017540A (zh)
CN (1) CN1178939C (zh)
AR (1) AR028958A1 (zh)
AT (1) ATE322492T1 (zh)
AU (2) AU7037001A (zh)
BG (1) BG107348A (zh)
BR (1) BR0102377A (zh)
CA (1) CA2411766C (zh)
CZ (1) CZ20024114A3 (zh)
DE (1) DE60118560T2 (zh)
DK (1) DK1294720T3 (zh)
EA (1) EA005598B1 (zh)
EE (1) EE200200690A (zh)
ES (1) ES2261433T3 (zh)
HK (1) HK1057558A1 (zh)
HR (1) HRP20021003A2 (zh)
HU (1) HUP0301105A2 (zh)
IL (1) IL152819A0 (zh)
MX (1) MXPA02012205A (zh)
MY (1) MY130375A (zh)
NO (1) NO323830B1 (zh)
NZ (1) NZ523549A (zh)
PE (1) PE20020083A1 (zh)
PL (1) PL360370A1 (zh)
PT (1) PT1294720E (zh)
SA (1) SA01220202B1 (zh)
SK (1) SK17722002A3 (zh)
TW (1) TWI270547B (zh)
UA (1) UA74834C2 (zh)
UY (1) UY26767A1 (zh)
WO (1) WO2001096338A1 (zh)
YU (1) YU94202A (zh)
ZA (1) ZA200209807B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716836B2 (en) 2001-03-22 2004-04-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6673791B2 (en) * 2001-07-30 2004-01-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6706706B2 (en) * 2002-03-27 2004-03-16 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
US6806265B2 (en) * 2002-05-16 2004-10-19 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
US6759533B2 (en) * 2002-06-28 2004-07-06 Boehringer Ingelheim Pharmaceuticals, Inc. Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors
US7642277B2 (en) 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
WO2004054586A1 (en) * 2002-12-16 2004-07-01 Boehringer Ingelheim International Gmbh Use of a combination containing a non-nucleoside reverse transcriptase inhibitor (nnrti) with an inhibitor of cytochrome p450, such as protease inhibitors
EP1610782A1 (en) * 2003-03-27 2006-01-04 Boehringer Ingelheim International GmbH Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound
US7309700B2 (en) * 2004-04-02 2007-12-18 Boehringer Ingelheim International Gmbh Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2′,3′-e] [1,4]diazepin-6-one
US20060025480A1 (en) 2004-08-02 2006-02-02 Boehringer Ingelheim International Gmbh Benzoic acid derivatives as non nucleoside reverse transcriptase inhibitors
US7151174B2 (en) 2004-11-05 2006-12-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for making a non-nucleoside HIV-1 reverse transcriptase inhibitor
US7282583B2 (en) * 2005-12-05 2007-10-16 Boehringer Ingelheim International Gmbh Process for making 5,11-Dihydro-11-ethyl-5-methyl-8{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-di pyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one
EP2085390A1 (en) 2008-01-31 2009-08-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
EP2417140B1 (en) * 2009-04-09 2014-11-26 Boehringer Ingelheim International GmbH Inhibitors of hiv replication

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
US5705499A (en) * 1995-10-06 1998-01-06 Boehringer Ingelheim Pharmaceuticals, Inc. 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection

Also Published As

Publication number Publication date
PE20020083A1 (es) 2002-02-28
HUP0301105A2 (hu) 2003-08-28
SA01220202B1 (ar) 2006-09-05
ATE322492T1 (de) 2006-04-15
CA2411766C (en) 2006-05-23
YU94202A (sh) 2005-11-28
IL152819A0 (en) 2003-06-24
EP1294720B1 (en) 2006-04-05
DE60118560D1 (de) 2006-05-18
EA005598B1 (ru) 2005-04-28
UA74834C2 (en) 2006-02-15
NO20025844L (no) 2002-12-05
EA200201255A1 (ru) 2003-06-26
DE60118560T2 (de) 2006-09-28
BR0102377A (pt) 2002-02-19
CN1178939C (zh) 2004-12-08
CZ20024114A3 (cs) 2003-04-16
PL360370A1 (en) 2004-09-06
NO323830B1 (no) 2007-07-09
PT1294720E (pt) 2006-06-30
ZA200209807B (en) 2003-10-16
NO20025844D0 (no) 2002-12-05
JP2004502787A (ja) 2004-01-29
AU7037001A (en) 2001-12-24
MY130375A (en) 2007-06-29
AR028958A1 (es) 2003-05-28
WO2001096338A1 (en) 2001-12-20
HRP20021003A2 (en) 2005-02-28
EE200200690A (et) 2004-06-15
DK1294720T3 (da) 2006-07-31
CN1436189A (zh) 2003-08-13
US6420359B1 (en) 2002-07-16
AU2001270370B2 (en) 2006-08-03
UY26767A1 (es) 2002-01-31
MXPA02012205A (es) 2003-09-10
SK17722002A3 (sk) 2003-06-03
ES2261433T3 (es) 2006-11-16
US20020028807A1 (en) 2002-03-07
EP1294720A1 (en) 2003-03-26
BG107348A (bg) 2004-06-30
TWI270547B (en) 2007-01-11
KR20030017540A (ko) 2003-03-03
JP3923894B2 (ja) 2007-06-06
CA2411766A1 (en) 2001-12-20
NZ523549A (en) 2004-08-27

Similar Documents

Publication Publication Date Title
HK1057558A1 (en) Non-nucleoside reverse transcriptase inhibitors.
SI1585739T1 (sl) Substituirani arilciklopropilacetamidi kot aktivatorji glukokinaze
AR077416A2 (es) Compuesto polimorfo estable de flibanserina , procedimiento industrial para su preparacion y uso del mismo para preparar medicamentos
NO20045152L (no) Ikke-nukleosid-reverstranskriptaseinhibitorer
WO2007081569A3 (en) Cetp inhibitors
EP1354880A4 (en) HALOGEN COMPOUNDS HAVING AGONISM TOWARDS THROMBOPOIETIN RECEPTOR
JO2035B1 (en) Pyrazine compounds
WO2008005519A3 (en) Novel pyridazine compound and use thereof
HUP0300480A2 (hu) 2-Acil-indol-származékok és tumorellenes szerként történő alkalmazásuk
CA2495721A1 (en) Non-nucleoside reverse transcriptase inhibitors
AR054386A1 (es) Moduladores de quinasas con estructuras de alquiloquinolina y alquilquinazolina
MX2021011286A (es) Compuestos de heterociclil(fenil)metanol útiles en el tratamiento de la hiperglucemia.
TW200616933A (en) Benzoic acid derivatives as non-nucleoside reverse transcriptase inhibitors
WO2002024663A3 (en) Pyrimidine compounds and their use
WO2003035620A1 (fr) Compose bicyclique
RS50229B (sr) Analozi vitamina d3
AU572660B2 (en) Bis (4-aminophenyl) sulfones
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
GB9907458D0 (en) Processes for preparing pesticidal intermediates
MXPA03007966A (es) Inhibidores de transcriptasa reversa sin nucleosido.
TR200100070A2 (tr) Bileşim
TW198680B (zh)
IS7378A (is) Lyfjasamsetningar sem samanstanda af 2-(4-etoxý-fenýl)-3-(4-metansúl-fónýl-fenýl)-pýrasóló 1,5-bípýridasín á nanóagna formi
UA96296C2 (en) Pyridazine compounds and use thereof
UA89970C2 (ru) Гетероциклические соединения и активаторы рецептора тромбопоэтина

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080614